当前位置:首页 - 行情中心 - 益盛药业(002566) - 财务分析 - 现金流量表

益盛药业

(002566)

  

流通市值:18.80亿  总市值:26.84亿
流通股本:2.32亿   总股本:3.31亿

现金流量表

报告期2025-09-302025-06-302025-03-312024-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金519,011,690.96351,421,944.18171,609,187.91752,168,533.09
  收到的税费返还571,542.12412,733.35160,002.081,883,022.68
  收到其他与经营活动有关的现金16,139,916.6611,179,229.4910,483,337.4125,745,128.31
  经营活动现金流入小计535,723,149.74363,013,907.02182,252,527.4779,796,684.08
  购买商品、接受劳务支付的现金65,603,422.444,501,620.218,725,169.4138,210,584.96
  支付给职工以及为职工支付的现金87,882,445.8959,205,768.928,835,145.66122,686,571.6
  支付的各项税费68,038,842.6246,110,323.9623,424,985.5298,533,066.17
  支付其他与经营活动有关的现金272,649,594.8179,847,250.389,227,745.62361,422,250.03
  经营活动现金流出小计494,174,305.71329,664,963.36160,213,046.2720,852,472.76
  经营活动产生的现金流量净额41,548,844.0333,348,943.6622,039,481.258,944,211.32
二、投资活动产生的现金流量:
  收回投资收到的现金450,000,000450,000,000119,841,226.87150,000,000
  取得投资收益收到的现金11,287,510.4511,287,510.45-5,285,761.43
  处置固定资产、无形资产和其他长期资产收回的现金净额594,278.52594,278.52155,928.17447,746.73
  投资活动现金流入小计461,881,788.97461,881,788.97119,997,155.04155,733,508.16
  购建固定资产、无形资产和其他长期资产支付的现金13,035,878.58,860,853.377,425,323.9915,941,708.9
  投资支付的现金450,036,700450,000,000129,864,229.16515,000,000
  投资活动现金流出小计463,072,578.5458,860,853.37137,289,553.15530,941,708.9
  投资活动产生的现金流量净额-1,190,789.533,020,935.6-17,292,398.11-375,208,200.74
三、筹资活动产生的现金流量:
  取得借款收到的现金348,000,000348,000,000215,000,000600,000,000
  筹资活动现金流入小计348,000,000348,000,000215,000,000600,000,000
  偿还债务支付的现金310,000,000310,000,000175,000,000630,100,000
  分配股利、利润或偿付利息支付的现金42,304,293.539,052,916.553,435,021.3161,635,448.18
  支付其他与筹资活动有关的现金5,553,296.054,816,000.12,446,730.818,254,359.85
  筹资活动现金流出小计357,857,589.55353,868,916.65180,881,752.12699,989,808.03
  筹资活动产生的现金流量净额-9,857,589.55-5,868,916.6534,118,247.88-99,989,808.03
四、汇率变动对现金及现金等价物的影响-2.34--2.31
五、现金及现金等价物净增加额30,500,464.9530,500,964.9538,865,330.97-416,253,799.76
  加:期初现金及现金等价物余额71,479,841.1971,479,841.1971,479,841.19487,733,640.95
  期末现金及现金等价物余额101,980,306.14101,980,806.14110,345,172.1671,479,841.19
补充资料:
  净利润-19,826,023.74-50,656,393.82
  资产减值准备-1,981,582.18-1,613,107.85
  固定资产和投资性房地产折旧-19,083,407.53-39,925,066.39
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-19,083,407.53-39,925,066.39
  无形资产摊销-1,341,971.16-2,834,564.61
  长期待摊费用摊销-333,267.42-625,681.97
  处置固定资产、无形资产和其他长期资产的损失--282,362.32--291,436.9
  固定资产报废损失-231,142.14-269,233.15
  公允价值变动损失-5,163,499.61--6,689,479.59
  财务费用-6,526,525.43-13,844,033.12
  投资损失--11,471,517.38--5,285,761.43
  递延所得税--1,276,523.4-505,753.95
  其中:递延所得税资产减少--597,337.31--528,406.01
    递延所得税负债增加--679,186.09-1,034,159.96
  存货的减少-13,355,480.87--11,331,993.1
  经营性应收项目的减少--33,163,097.27-5,213,658.64
  经营性应付项目的增加-9,455,763.49--37,261,382.37
  现金的期末余额-101,980,806.14-71,479,841.19
  减:现金的期初余额-71,479,841.19-487,733,640.95
  现金及现金等价物的净增加额-30,500,964.95--416,253,799.76
公告日期2025-10-272025-08-232025-04-242025-04-18
审计意见(境内)标准无保留意见
TOP↑